A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow

Miriam Galbusera, Andrea Remuzzi, Ariela Benigni, Chiara Rossi, Giuseppe Remuzzi

Research output: Contribution to journalArticle

Abstract

Clinical manifestations of thrombotic microangiopathles (TMA) are secondary to platelet aggregation and thrombotic occlusion of the microvasculature of the affected organs. Abnormalities in von Willebrand factor (vWF) in these patients were considered instrumental in promoting the process leading to microvascular thrombosis. We evaluated the capacity of plasma in these patients to induce adhesion of normal platelets and thrombus formation under conditions of controlled fluid shear stress. We also studied vWF multimeric distribution to establish whether abnormalities of this glycoprotein correlate with platelet adhesion and thrombus formation. Plasma from patients in the acute phase and remission showed the same capacity to induce platelet adhesion and thrombus formation at a low level of shear rate (600 sec -1) as plasma from control subjects. At a high shear rate (1,500 sec -1), platelet adhesion and thrombus dimensions were significantly increased (P <0.05) by plasma from patients with TMA compared with controls. The capacity to enhance thrombus formation at high shear stress was present during the acute phase and disease remission and did not correlate with the presence of unusually large vWF multimers. Increased thrombus formation with patient plasma is completely normalized by blocking the interaction of vWF with the platelet receptors, glycoprotein (GP)Ib and GPIIb-IIIa, suggesting that the phenomenon is completely mediated by vWF. Our results suggest the possibility of an intrinsically altered vWF molecule in these patients that is probably more effective than normal vWF in mediating platelet adhesion and thrombus formation. (C) 2000 by the National Kidney Foundation, Inc.

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalAmerican Journal of Kidney Diseases
Volume36
Issue number4
Publication statusPublished - 2000

Fingerprint

Thrombotic Microangiopathies
von Willebrand Factor
Thrombosis
Blood Platelets
Platelet Glycoprotein GPIb-IX Complex
Platelet Membrane Glycoproteins
Acute Disease
Microvessels
Platelet Aggregation
Glycoproteins

Keywords

  • Platelet
  • Shear stress
  • Thrombotic microangiopathy (TMA)
  • Von Willebrand factor (vWF)

ASJC Scopus subject areas

  • Nephrology

Cite this

@article{d18c5693dd64413c9333dadb7f64d08b,
title = "A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow",
abstract = "Clinical manifestations of thrombotic microangiopathles (TMA) are secondary to platelet aggregation and thrombotic occlusion of the microvasculature of the affected organs. Abnormalities in von Willebrand factor (vWF) in these patients were considered instrumental in promoting the process leading to microvascular thrombosis. We evaluated the capacity of plasma in these patients to induce adhesion of normal platelets and thrombus formation under conditions of controlled fluid shear stress. We also studied vWF multimeric distribution to establish whether abnormalities of this glycoprotein correlate with platelet adhesion and thrombus formation. Plasma from patients in the acute phase and remission showed the same capacity to induce platelet adhesion and thrombus formation at a low level of shear rate (600 sec -1) as plasma from control subjects. At a high shear rate (1,500 sec -1), platelet adhesion and thrombus dimensions were significantly increased (P <0.05) by plasma from patients with TMA compared with controls. The capacity to enhance thrombus formation at high shear stress was present during the acute phase and disease remission and did not correlate with the presence of unusually large vWF multimers. Increased thrombus formation with patient plasma is completely normalized by blocking the interaction of vWF with the platelet receptors, glycoprotein (GP)Ib and GPIIb-IIIa, suggesting that the phenomenon is completely mediated by vWF. Our results suggest the possibility of an intrinsically altered vWF molecule in these patients that is probably more effective than normal vWF in mediating platelet adhesion and thrombus formation. (C) 2000 by the National Kidney Foundation, Inc.",
keywords = "Platelet, Shear stress, Thrombotic microangiopathy (TMA), Von Willebrand factor (vWF)",
author = "Miriam Galbusera and Andrea Remuzzi and Ariela Benigni and Chiara Rossi and Giuseppe Remuzzi",
year = "2000",
language = "English",
volume = "36",
pages = "695--702",
journal = "American Journal of Kidney Diseases",
issn = "0272-6386",
publisher = "W.B. Saunders Ltd",
number = "4",

}

TY - JOUR

T1 - A novel interpretation of the role of von Willebrand factor in thrombotic microangiopathies based on platelet adhesion studies at high shear rate flow

AU - Galbusera, Miriam

AU - Remuzzi, Andrea

AU - Benigni, Ariela

AU - Rossi, Chiara

AU - Remuzzi, Giuseppe

PY - 2000

Y1 - 2000

N2 - Clinical manifestations of thrombotic microangiopathles (TMA) are secondary to platelet aggregation and thrombotic occlusion of the microvasculature of the affected organs. Abnormalities in von Willebrand factor (vWF) in these patients were considered instrumental in promoting the process leading to microvascular thrombosis. We evaluated the capacity of plasma in these patients to induce adhesion of normal platelets and thrombus formation under conditions of controlled fluid shear stress. We also studied vWF multimeric distribution to establish whether abnormalities of this glycoprotein correlate with platelet adhesion and thrombus formation. Plasma from patients in the acute phase and remission showed the same capacity to induce platelet adhesion and thrombus formation at a low level of shear rate (600 sec -1) as plasma from control subjects. At a high shear rate (1,500 sec -1), platelet adhesion and thrombus dimensions were significantly increased (P <0.05) by plasma from patients with TMA compared with controls. The capacity to enhance thrombus formation at high shear stress was present during the acute phase and disease remission and did not correlate with the presence of unusually large vWF multimers. Increased thrombus formation with patient plasma is completely normalized by blocking the interaction of vWF with the platelet receptors, glycoprotein (GP)Ib and GPIIb-IIIa, suggesting that the phenomenon is completely mediated by vWF. Our results suggest the possibility of an intrinsically altered vWF molecule in these patients that is probably more effective than normal vWF in mediating platelet adhesion and thrombus formation. (C) 2000 by the National Kidney Foundation, Inc.

AB - Clinical manifestations of thrombotic microangiopathles (TMA) are secondary to platelet aggregation and thrombotic occlusion of the microvasculature of the affected organs. Abnormalities in von Willebrand factor (vWF) in these patients were considered instrumental in promoting the process leading to microvascular thrombosis. We evaluated the capacity of plasma in these patients to induce adhesion of normal platelets and thrombus formation under conditions of controlled fluid shear stress. We also studied vWF multimeric distribution to establish whether abnormalities of this glycoprotein correlate with platelet adhesion and thrombus formation. Plasma from patients in the acute phase and remission showed the same capacity to induce platelet adhesion and thrombus formation at a low level of shear rate (600 sec -1) as plasma from control subjects. At a high shear rate (1,500 sec -1), platelet adhesion and thrombus dimensions were significantly increased (P <0.05) by plasma from patients with TMA compared with controls. The capacity to enhance thrombus formation at high shear stress was present during the acute phase and disease remission and did not correlate with the presence of unusually large vWF multimers. Increased thrombus formation with patient plasma is completely normalized by blocking the interaction of vWF with the platelet receptors, glycoprotein (GP)Ib and GPIIb-IIIa, suggesting that the phenomenon is completely mediated by vWF. Our results suggest the possibility of an intrinsically altered vWF molecule in these patients that is probably more effective than normal vWF in mediating platelet adhesion and thrombus formation. (C) 2000 by the National Kidney Foundation, Inc.

KW - Platelet

KW - Shear stress

KW - Thrombotic microangiopathy (TMA)

KW - Von Willebrand factor (vWF)

UR - http://www.scopus.com/inward/record.url?scp=0033810719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033810719&partnerID=8YFLogxK

M3 - Article

C2 - 11007670

AN - SCOPUS:0033810719

VL - 36

SP - 695

EP - 702

JO - American Journal of Kidney Diseases

JF - American Journal of Kidney Diseases

SN - 0272-6386

IS - 4

ER -